| Overview |
| bs-10100r-pe-cy5-100ul |
| HSP90 alpha Polyclonal Antibody, PE-Cy5 Conjugated |
| WB |
| Human, Mouse |
| Rat, Dog, Cow, Sheep, Pig, Horse, Chicken, Rabbit |
| Specifications |
| PE-Cy5 |
| Rabbit |
| KLH conjugated synthetic peptide derived from human HSP90 alpha |
| 401-500/732 |
| Polyclonal |
| IgG |
| 1ug/ul |
| Purified by Protein A. |
| Aqueous buffered solution containing 0.01M TBS (pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol. |
| Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles. |
| Target |
| 3320 |
| P07900 |
| Cytoplasm, Cell membrane |
| EL52; HSPN; LAP2; HSP86; HSPC1; HSPCA; Hsp89; Hsp9; LAP-2; HSP89A; HSP9A; HSP9N; HSPCAL1; HSPCAL4; Heat shock protein HSP 9-alpha; Heat shock 86 kDa; HSP 86; Lipopolysaccharide-associated protein 2; LPS-associated protein 2; Renal carcinoma antigen NY-REN-38; HSP9AA1 |
| Molecular chaperone that promotes the maturation, structural maintenance and proper regulation of specific target proteins involved for instance in cell cycle control and signal transduction. Undergoes a functional cycle that is linked to its ATPase activity. This cycle probably induces conformational changes in the client proteins, thereby causing their activation. Interacts dynamically with various co-chaperones that modulate its substrate recognition, ATPase cycle and chaperone function. Binds bacterial lipopolysaccharide (LPS) et mediates LPS-induced inflammatory response, including TNF secretion by monocytes. |
| Application Dilution |
| WB |
1:300-5000 |
Powered by Bioz